| Literature DB >> 29141033 |
Qingling Jiang1, Chenchang Bao1, Ya'nan Yang1, An Liu1, Fang Liu1, Huiyang Huang1, Haihui Ye1,2.
Abstract
In crustaceans, muscle growth and development is complicated, and to date substantial knowledge gaps exist. In this study, the claw muscle, hepatopancreas and nervous tissue of the mud crab (Scylla paramamosain) were collected at three fattening stages for sequence by the Illumina sequencing. A total of 127.87 Gb clean data with no less than 3.94 Gb generated for each sample and the cycleQ30 percentages were more than 86.13% for all samples. De Bruijn assembly of these clean data produced 94,853 unigenes, thereinto, 50,059 unigenes were found in claw muscle. A total of 121 differentially expressed genes (DEGs) were revealed in claw muscle from the three fattening stages with a Padj value < 0.01, including 63 genes with annotation. Functional annotation and enrichment analysis showed that the DEGs clusters represented the predominant gene catalog with roles in biochemical processes (glycolysis, phosphorylation and regulation of transcription), molecular function (ATP binding, 6-phosphofructokinase activity, and sequence-specific DNA binding) and cellular component (6-phosphofructokinase complex, plasma membrane, and integral component of membrane). qRT-PCR was employed to further validate certain DEGs. Single nucleotide polymorphism (SNP) analysis obtained 159,322, 125,963 and 166,279 potential SNPs from the muscle transcriptome at stage B, stage C and stage D, respectively. In addition, there were sixteen neuropeptide transcripts being predicted in the claw muscle. The present study provides a comprehensive transcriptome of claw muscle of S. paramamosain during fattening, providing a basis for screening the functional genes that may affect muscle growth of S. paramamosain.Entities:
Mesh:
Year: 2017 PMID: 29141033 PMCID: PMC5687733 DOI: 10.1371/journal.pone.0188067
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The primers used in qRT-PCR.
| Name | Sequence (5'→3') |
|---|---|
Summary of assembly statistics in S. paramamosain.
| Samples | Clean sequencing reads | Alignment statistics | Assembled statistics | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total reads | Total bases (bp) | Percentage of GC content (%) | Mapped Reads | Mapped Ratio | Number of assembled transcripts | Total size of assembled transcripts (bp) | Number of assembled transcripts > 1K nt | Mean assembled transcripts size | ||
| H1 | 20,112,209 | 5,067,576,969 | 53.16% | 15,584,072 | 77.49% | 183,760 | 291,529,594 | 80,375 | 1,586.47 | |
| H2 | 20,861,851 | 5,256,378,014 | 54.16% | 16,429,685 | 78.75% | |||||
| H3 | 18,655,143 | 4,700,470,289 | 51.38% | 13,716,052 | 73.52% | |||||
| M1 | 16,849,437 | 4,245,263,966 | 55.26% | 13,273,186 | 78.78% | |||||
| M2 | 16,742,590 | 4,218,417,849 | 51.62% | 12,487,988 | 74.59% | |||||
| M3 | 18,484,051 | 4,656,967,106 | 54.06% | 14,370,747 | 77.75% | |||||
| Y1 | 19,623,105 | 4,944,053,452 | 50.84% | 15,563,551 | 79.31% | |||||
| Y2 | 18,459,116 | 4,650,758,177 | 51.05% | 14,275,073 | 77.33% | |||||
| Y3 | 21,655,410 | 5,456,088,041 | 49.93% | 17,013,947 | 78.57% | |||||
| H4 | 20,545,288 | 5,176,538,520 | 49.10% | 16,426,588 | 79.95% | |||||
| H5 | 17,907,718 | 4,511,999,917 | 49.20% | 14,332,425 | 80.03% | |||||
| H6 | 19,114,710 | 4,816,235,708 | 49.41% | 15,239,510 | 79.73% | |||||
| M4 | 18,637,615 | 4,695,854,468 | 52.79% | 14,042,531 | 75.35% | |||||
| M5 | 16,469,261 | 4,149,634,815 | 53.00% | 12,736,660 | 77.34% | |||||
| M6 | 16,937,402 | 4,267,442,962 | 54.92% | 13,057,495 | 77.09% | |||||
| Y4 | 19,271,980 | 4,855,825,679 | 57.30% | 12,619,570 | 65.48% | |||||
| Y5 | 20,509,246 | 5,167,672,936 | 53.67% | 15,338,613 | 74.79% | |||||
| Y6 | 23,266,613 | 5,862,342,086 | 53.76% | 17,486,492 | 75.16% | |||||
| H7 | 23,294,003 | 5,869,102,468 | 50.08% | 17,073,577 | 73.30% | |||||
| H8 | 18,769,483 | 4,729,138,446 | 51.02% | 14,332,336 | 76.36% | |||||
| H9 | 17,573,006 | 4,427,451,799 | 50.37% | 11,698,496 | 66.57% | |||||
| M7 | 15,627,359 | 3,937,273,175 | 54.37% | 12,298,736 | 78.70% | |||||
| M8 | 16,849,106 | 4,245,259,370 | 54.04% | 13,333,783 | 79.14% | |||||
| M9 | 17,351,281 | 4,371,802,474 | 54.50% | 13,739,437 | 79.18% | |||||
| Y7 | 17,744,413 | 4,470,891,768 | 50.18% | 13,908,009 | 78.38% | |||||
| Y8 | 18,587,160 | 4,683,370,686 | 49.85% | 14,497,722 | 78.00% | |||||
| Y9 | 17,615,004 | 4,438,434,274 | 50.26% | 13,946,640 | 79.17% | |||||
Note: H1-3, H4-6, H7-9: the biological replicates of hepatopancreas at stage B, stage D, stage C; Y1-3, Y4-6, Y7-9: the biological replicates of nervous tissue at stage B, stage D, stage C; M1-3, M4-6, M7-9: the biological replicates of claw muscle at stage B, stage D, stage C.
Fig 1Length distribution summary of transcripts identified in S. paramamosain transcriptome data sets.
Fig 2Nr homologous species distribution.
The number of aligned genes and the percentage of which in all annotated genes were recorded in brackets.
Top 20 annotations of S. paramamosain transcriptome with the highest bit score.
| Description | Accession ID | Organism Scientific name (common name) | Alignment length (amino acids) | E value | Bit Score | Type |
|---|---|---|---|---|---|---|
| Dynein heavy chain, cytoplasmic | KDR21358.1 | 3,661 | 0 | 7,494 | Full length | |
| Ryanodine receptor | AGH68757.1 | 3,178 | 0 | 6,187 | Partial | |
| Putative low-density lipoprotein receptor | JAB58180.1 | 2,748 | 0 | 5,489 | Partial | |
| Cj-cadherin | BAD91056.1 | 2,669 | 0 | 5,437 | Full length | |
| Projectin | BAC66140.1 | 2,579 | 0 | 5,376 | Partial | |
| Uncharacterized protein | NV12534-PA | 2,168 | 0 | 4,564 | Partial | |
| Pre-mRNA-processing-splicing factor, putative | EEB14455.1 | 2,147 | 0 | 4,354 | Full length | |
| Uncharacterized protein | SMAR010770-PA | 2,194 | 0 | 4,335 | Partial | |
| Projectin | BAC66140.1 | 2,184 | 0 | 4,221 | Partial | |
| Uncharacterized protein | SMAR006389-PA | 2,399 | 0 | 4,118 | Partial | |
| Spectrin alpha chain | KDR23504.1 | 2,010 | 0 | 4,052 | Full length | |
| target of rapamycin | AHX84170.1 | 2,105 | 0 | 4,009 | Full length | |
| microtubule-actin cross-linking factor 1-like | XP_008560478.1 | 2,106 | 0 | 3,903 | Full length | |
| spectrin beta chain, non-erythrocytic 2 isoform X3 | XP_011150755.1 | 2,057 | 0 | 3,890 | Full length | |
| neurofibromin | XP_008200683.1 | 1,924 | 0 | 3,821 | Full length | |
| E3 ubiquitin-protein ligase HERC2-like | XP_005096225.1 | 2,274 | 0 | 3,759 | Full length | |
| fat-like cadherin-related tumor suppressor homolog | XP_003491311.1 | 2,096 | 0 | 3,674 | Partial | |
| myosin-VIIa-like isoform X1 | XP_006621154.1 | 1,731 | 0 | 3,569 | Full length | |
| Laminin subunit alpha | KDR13939.1 | 1,761 | 0 | 3,521 | Partial | |
| I-connectin | BAB64297.1 | 1,698 | 0 | 3,422 | Full length |
Putative neuropeptide precursors in the muscle transcriptome of S. paramamosain.
| Peptide families | Accession Num. | Size (bp) | Size (aa) | Best Blastx Match | |||
|---|---|---|---|---|---|---|---|
| Species name | E-value | Ident | Accession Num. | ||||
| B-type allatostatin | K7RY75 | 1754 | 314 | 0.0 | 100% | ALQ28584.1 | |
| short Neuropeptide F | U5EU21 | 1533 | 126 | 5e-89 | 100% | ALQ28574.1 | |
| Neuroparsin1 | A0A023PY98 | 1782 | 101 | 5e-66 | 100% | ALQ28570.1 | |
| Neuroparsin2 | W5S2B1 | 438 | 106 | 2e-71 | 100% | ALQ28588.1 | |
| Neuroparsin3 | PF07327.6 | 794 | 97 | 2e-65 | 100% | ALQ28589.1 | |
| Neuroparsin4 | W5S2B1 | 2399 | 102 | 2e-67 | 100% | ALQ28571.1 | |
| CHH1 | F2YLB0 | 1117 | 127 | 5e-91 | 99% | ALQ28582.1 | |
| CHH2 | H9ZJK3 | 1847 | 140 | 2e-99 | 100% | ALQ28572.1 | |
| Orcokinin1 | E9FTU8 | 1421 | 121 | 7E-83 | 100% | ALQ28595.1 | |
| Diuretic hormone 31 | D2IJD5 | 1399 | 146 | 3e-100 | 100% | ALQ28573.1 | |
| Tachykinin | Q767J5 | 756 | 222 | 7e-156 | 99% | ALQ28591.1 | |
| Myosuppressin | B5BP38 | 803 | 100 | 4e-68 | 100% | ALQ28580.1 | |
| bursicon hormone alpha subunit | C3S7D8 | 1419 | 73 | 9e-45 | 99% | ACG50067.1 | |
| putative insulin-like protein growth factor binding protein | E4VP27 | 718 | 96 | 8e-06 | 56% | JAT91097.1 | |
| insulin-like androgenic gland factor | A0A075INW9 | 879 | 68 | 6e-43 | 99% | AFY09903.1 | |
Fig 3The classification of unigenes in three GO categories in S. paramamosain.
The x-axis indicated GO process; the y-axis on the left side indicated the percentage of the unigenes of this process in all genes; the y-axis on the right side indicated the number of unigenes in the process.
Fig 4The COG function classification in S. paramamosain.
The x-axis indicated COG function; the y-axis indicated the number of unigenes.
Statistics of SNPs in S. paramamosain.
| Samples | HomoSNP | HeteSNP | AllSNP |
|---|---|---|---|
| stage B | 143,546 | 15,776 | 159,322 |
| stage C | 111,625 | 14,338 | 125,963 |
| stage D | 144,943 | 21,336 | 166,279 |
Note: HomoSNP: number of Homozygous SNP; HeteSNP: number of Hybrid SNP; All SNP: all number of SNP.
Fig 5SNP density in S. paramamosain.
The x-axis indicated SNP number per Kb; the y-axis indicated the number of unigene.
Fig 6FPKM box chart in S. paramamosain.
The x-axis indicated the samples; the y-axis indicated the logarithm of FPKM. The figure shows the overall level and the degree of dispersion of gene expression. The horizontal line in the box represents the expression level of 50% genes in the corresponding sample; black spots represent discrete genes, above the box for high expression, below the box for the low expression.
Statistics of DEGs in the muscle transcriptome in S. paramamosain.
| All genes | Significant DEGs | |||||
|---|---|---|---|---|---|---|
| Cond. 1 | Cond.2 | Total | Up- | Down- | Up- | Down- |
| stage D | stage B | 13,323 | 5,907 | 7,416 | 2 | 0 |
| stage C | stage B | 10,171 | 5,204 | 4,967 | 21 | 2 |
| stage C | stage D | 11,153 | 5,984 | 5,169 | 29 | 70 |
Note: Cond.: condition.
Fig 7The DEGs of muscle of S. paramamosain at different stages.
pfk-1: Phosphofructokinase-1; eno: Enolase; gapdh: Glyceraldehyde-3-phosphatede hydrogenase; Su(H): Suppressor of Hairless; hspb6: alpha crystallin family; 3-hao: 3-hydroxyanthranilic acid dioxygenase; mfs: Major Facilitator Superfamily; ak: Arginine kinase; cuti: arthrodial cuticle protein; mlc: myosin light chain; 18s RNA was used as reference gene. Values denoted by different numbers of asterisks were significantly different when compared by ANOVA (“**” p < 0.01; “*” p < 0.05).
Fig 8The GO categories of DEGs of muscle.
(a) The GO categories of the DEGs in stage D specimens and stage B specimens. The x-axis indicated GO process; the y-axis on the left side indicated the percentage of the DEGs; the y-axis on the right side indicated the number of the DEGs (up) and all unigenes (down) in the process; (b) The GO categories of the DEGs in stage C specimens and stage B specimens; (c) The GO categories of the DEGs in stage D specimens and stage C specimens.
The GO terms with significant DEGs of muscle of S. paramamosain.
| GO ID | GO term | All genes | DEGs | DEG IDs |
|---|---|---|---|---|
| GO:0019363 | pyridine nucleotide biosynthetic process | 5 | 1 | c51072.graph_c0 |
| GO:0006355 | regulation of transcription, DNA-templated | 175 | 1 | c40124.graph_c0 |
| GO:0046427 | positive regulation of JAK-STAT cascade | 5 | 1 | c2761.graph_c0 |
| GO:0008039 | synaptic target recognition | 6 | 1 | c51381.graph_c0 |
| GO:0044765 | single-organism transport | 54 | 1 | c41045.graph_c0 |
| GO:0015918 | sterol transport | 1 | 1 | c51381.graph_c0 |
| GO:0055085 | transmembrane transport | 1 | 81 | c5211.graph_c0 |
| GO:0061057 | peptidoglycan recognition protein signaling pathway | 1 | 2 | c51381.graph_c0 |
| GO:0006810 | Transport | 1 | 184 | c2761.graph_c0 |
| GO:0055092 | sterol homeostasis | 1 | 1 | c51381.graph_c0 |
| GO:0019752 | carboxylic acid metabolic process | 1 | 6 | c51072.graph_c0 |
| GO:0045456 | ecdysteroid biosynthetic process | 1 | 2 | c51381.graph_c0 |
| GO:0070891 | lipoteichoic acid binding | 1 | 1 | c51381.graph_c0 |
| GO:0016491 | oxidoreductase activity | 1 | 206 | c51072.graph_c0 |
| GO:0042834 | peptidoglycan binding | 1 | 1 | c51381.graph_c0 |
| GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides | 1 | 4 | c34326.graph_c0 |
| GO:0030882 | lipid antigen binding | 1 | 1 | c51381.graph_c0 |
| GO:0042302 | structural constituent of cuticle | 3 | 52 | c53503.graph_c0;c52677.graph_c0;c54621.graph_c0 |
| GO:0046914 | transition metal ion binding | 1 | 12 | c34326.graph_c0 |
| GO:0022891 | substrate-specific transmembrane transporter activity | 1 | 7 | c2761.graph_c0 |
| GO:0005215 | transporter activity | 1 | 44 | c5211.graph_c0 |
| GO:0043565 | sequence-specific DNA binding | 1 | 107 | c40124.graph_c0 |
| GO:0046872 | metal ion binding | 1 | 410 | c51072.graph_c0 |
| GO:0008270 | zinc ion binding | 1 | 214 | c40124.graph_c0 |
| GO:0003700 | sequence-specific DNA binding transcription factor activity | 1 | 135 | c40124.graph_c0 |
| GO:0001530 | lipopolysaccharide binding | 1 | 1 | c51381.graph_c0 |
| GO:0016021 | Cellular Component: integral component of membrane | 1 | 383 | c5211.graph_c0 |
| GO:0005886 | Cellular Component: plasma membrane | 1 | 132 | c5211.graph_c0 |
| GO:0016020 | Cellular Component: membrane | 1 | 376 | c27537.graph_c0 |
| GO:0005615 | Cellular Component: extracellular space | 1 | 25 | c51381.graph_c0 |
| GO:0042302 | structural constituent of cuticle | 1 | 52 | c39692.graph_c0 |
| GO:0045454 | cell redox homeostasis | 1 | 20 | c38096.graph_c1 |
| GO:0006497 | protein lipidation | 1 | 1 | c63835.graph_c0 |
| GO:0005975 | carbohydrate metabolic process | 1 | 56 | c46569.graph_c0 |
| GO:0006355 | regulation of transcription, DNA-templated | 2 | 175 | c49393.graph_c1;c45040.graph_c0 |
| GO:0016310 | Phosphorylation | 3 | 159 | c49263.graph_c1;c49263.graph_c0;c47972.graph_c0 |
| GO:0006096 | Glycolysis | 4 | 26 | c49263.graph_c1;c57401.graph_c0;c41007.graph_c0;c49263.graph_c0 |
| GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation | 1 | 1 | c63835.graph_c0 |
| GO:0035076 | ecdysone receptor-mediated signaling pathway | 1 | 1 | c45040.graph_c0 |
| GO:0006002 | fructose 6-phosphate metabolic process | 2 | 2 | c49263.graph_c1;c49263.graph_c0 |
| GO:0010506 | regulation of autophagy | 1 | 6 | c63835.graph_c0 |
| GO:0055114 | oxidation-reduction process | 1 | 223 | c57401.graph_c0 |
| GO:0006979 | response to oxidative stress | 1 | 20 | c20754.graph_c0 |
| GO:0009408 | response to heat | 1 | 15 | c20754.graph_c0 |
| GO:0055085 | transmembrane transport | 1 | 81 | c52669.graph_c0 |
| GO:0016311 | dephosphorylation | 1 | 27 | c25738.graph_c0 |
| GO:0043401 | steroid hormone mediated signaling pathway | 1 | 16 | c45040.graph_c0 |
| GO:0008340 | determination of adult lifespan | 1 | 54 | c20754.graph_c0 |
| GO:0004721 | phosphoprotein phosphatase activity | 1 | 47 | c25738.graph_c0 |
| GO:0016787 | hydrolase activity | 2 | 356 | c55187.graph_c0;c41007.graph_c0 |
| GO:0050661 | NADP binding | 1 | 9 | c57401.graph_c0 |
| GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity | 1 | 2 | c57401.graph_c0 |
| GO:0004634 | phosphopyruvate hydratase activity | 1 | 2 | c41007.graph_c0 |
| GO:0022857 | transmembrane transporter activity | 1 | 21 | c52669.graph_c0 |
| GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1 | 3 | c49393.graph_c1 |
| GO:0003872 | 6-phosphofructokinase activity | 2 | 2 | c49263.graph_c1;c49263.graph_c0 |
| GO:0030246 | carbohydrate binding | 1 | 20 | c51311.graph_c0 |
| GO:0005496 | steroid binding | 1 | 1 | c45040.graph_c0 |
| GO:0004054 | arginine kinase activity | 1 | 2 | c47972.graph_c0 |
| GO:0000287 | magnesium ion binding | 1 | 22 | c41007.graph_c0 |
| GO:0004884 | ecdysteroid hormone receptor activity | 1 | 1 | c45040.graph_c0 |
| GO:0003756 | protein disulfide isomerase activity | 1 | 5 | c38096.graph_c1 |
| GO:0042302 | structural constituent of cuticle | 2 | 52 | c53503.graph_c0;c39692.graph_c0 |
| GO:0000982 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity | 1 | 1 | c49393.graph_c1 |
| GO:0051287 | NAD binding | 1 | 18 | c57401.graph_c0 |
| GO:0043565 | sequence-specific DNA binding | 1 | 107 | c45040.graph_c0 |
| GO:0008184 | glycogen phosphorylase activity | 1 | 1 | c46569.graph_c0 |
| GO:0008270 | zinc ion binding | 1 | 214 | c45040.graph_c0 |
| GO:0005509 | calcium ion binding | 1 | 132 | c27508.graph_c0 |
| GO:0005488 | binding | 1 | 451 | c48138.graph_c0 |
| GO:0005524 | ATP binding | 3 | 563 | c49263.graph_c0;c49263.graph_c1;c47972.graph_c0 |
| GO:0030170 | pyridoxal phosphate binding | 1 | 30 | c46569.graph_c0 |
| GO:0005634 | nucleus | 2 | 429 | c45040.graph_c0;c49393.graph_c1 |
| GO:0005886 | plasma membrane | 1 | 132 | c38096.graph_c1 |
| GO:0005737 | cytoplasm | 1 | 267 | c57401.graph_c0 |
| GO:0005945 | 6-phosphofructokinase complex | 2 | 2 | c49263.graph_c1;c49263.graph_c0 |
| GO:0000015 | phosphopyruvate hydratase complex | 1 | 2 | c41007.graph_c0 |
| GO:0016021 | integral component of membrane | 1 | 383 | c52669.graph_c0 |
| GO:0005740 | mitochondrial envelope | 1 | 4 | c52669.graph_c0 |
Fig 9The COG categories of the DEGs of muscle.
(a) The COG categories of the DEGs in stage D specimens and stage C specimens. The x-axis indicated COG process; the y-axis represented the number of the DEGs; (b) The COG categories of the DEGs of muscle in stage B specimens and stage C specimens.
Fig 10The KEGG pathways of the DEGs of muscle.
(a) The KEGG pathways of the DEGs in stage C specimens and stage B specimens. The x-axis indicated the proportion of annotated DEGs in the pathway. The numbers of genes in the pathway were recorded. The y-axis represented the pathway. The same color-coded pathway was in the same KEGG category; (b) The KEGG pathways of the DEGs of muscle in stage C specimens and stage D specimens.